Gilberto Lourenço Alves
AuthID: R-000-PDS
91
TITLE: Flavonoid compounds as reversal agents of the P-glycoprotein-mediated multidrug resistance: biology, chemistry and pharmacology Full Text
AUTHORS: Ana Ferreira; Sarah Pousinho; Ana Fortuna ; Amilcar Falcao ; Gilberto Alves;
PUBLISHED: 2015, SOURCE: PHYTOCHEMISTRY REVIEWS, VOLUME: 14, ISSUE: 2
AUTHORS: Ana Ferreira; Sarah Pousinho; Ana Fortuna ; Amilcar Falcao ; Gilberto Alves;
PUBLISHED: 2015, SOURCE: PHYTOCHEMISTRY REVIEWS, VOLUME: 14, ISSUE: 2
INDEXED IN:
Scopus
WOS


IN MY:
ORCID

92
TITLE: Clinical drug-drug interactions: Focus on venlafaxine
AUTHORS: Magalhaes, P; Alves, G; Lerena, AL; Falcao, A ;
PUBLISHED: 2015, SOURCE: Drug Metabolism and Personalized Therapy, VOLUME: 30, ISSUE: 1
AUTHORS: Magalhaes, P; Alves, G; Lerena, AL; Falcao, A ;
PUBLISHED: 2015, SOURCE: Drug Metabolism and Personalized Therapy, VOLUME: 30, ISSUE: 1
INDEXED IN:
Scopus

IN MY:
ORCID

93
TITLE: Direct nose-to-brain delivery of lamotrigine following intranasal administration to mice Full Text
AUTHORS: Ana Serralheiro; Gilberto Alves; Ana Fortuna ; Amilcar Falcao ;
PUBLISHED: 2015, SOURCE: INTERNATIONAL JOURNAL OF PHARMACEUTICS, VOLUME: 490, ISSUE: 1-2
AUTHORS: Ana Serralheiro; Gilberto Alves; Ana Fortuna ; Amilcar Falcao ;
PUBLISHED: 2015, SOURCE: INTERNATIONAL JOURNAL OF PHARMACEUTICS, VOLUME: 490, ISSUE: 1-2
94
TITLE: Clinical drug-drug interactions: focus on venlafaxine
AUTHORS: Paulo Magalhães; Gilberto Alves; Adrián LLerena; Amílcar Falcão ;
PUBLISHED: 2015, SOURCE: Drug Metabolism and Personalized Therapy, VOLUME: 30, ISSUE: 1
AUTHORS: Paulo Magalhães; Gilberto Alves; Adrián LLerena; Amílcar Falcão ;
PUBLISHED: 2015, SOURCE: Drug Metabolism and Personalized Therapy, VOLUME: 30, ISSUE: 1
95
TITLE: The pharmacology of simvastatin: From the mechanism of action to new therapeutic applications
AUTHORS: Fortuna, A ; Alves, G; Falcão, A ;
PUBLISHED: 2015, SOURCE: Simvastatin Delivery: Challenges and Opportunities
AUTHORS: Fortuna, A ; Alves, G; Falcão, A ;
PUBLISHED: 2015, SOURCE: Simvastatin Delivery: Challenges and Opportunities
INDEXED IN:
Scopus

IN MY:
ORCID

96
TITLE: Pharmacokinetics and bioanalysis to improve drug development
AUTHORS: Fortuna, A ; Alves, G; Falcão, A ;
PUBLISHED: 2015, SOURCE: Biomedical Chemistry: Current Trends and Developments
AUTHORS: Fortuna, A ; Alves, G; Falcão, A ;
PUBLISHED: 2015, SOURCE: Biomedical Chemistry: Current Trends and Developments
97
TITLE: Chiral chromatographic resolution of antiepileptic drugs and their metabolites: a challenge from the optimization to the application. Chiral chromatography of antiepileptic drugs and their metabolites Full Text
AUTHORS: Ana Fortuna ; Gilberto Alves; Amilcar Falcao ;
PUBLISHED: 2014, SOURCE: BIOMEDICAL CHROMATOGRAPHY, VOLUME: 28, ISSUE: 1
AUTHORS: Ana Fortuna ; Gilberto Alves; Amilcar Falcao ;
PUBLISHED: 2014, SOURCE: BIOMEDICAL CHROMATOGRAPHY, VOLUME: 28, ISSUE: 1
98
TITLE: Intranasal administration of carbamazepine to mice: A direct delivery pathway for brain targeting Full Text
AUTHORS: Ana Serralheiro; Gilberto Alves; Ana Fortuna ; Amilcar Falcao ;
PUBLISHED: 2014, SOURCE: EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, VOLUME: 60
AUTHORS: Ana Serralheiro; Gilberto Alves; Ana Fortuna ; Amilcar Falcao ;
PUBLISHED: 2014, SOURCE: EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, VOLUME: 60
99
TITLE: Herb-drug Pharmacokinetic Interaction between Carica Papaya Extract and Amiodarone in Rats
AUTHORS: Rodrigues, M; Alves, G; Francisco, J; Fortuna, A ; Falcao, A ;
PUBLISHED: 2014, SOURCE: JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, VOLUME: 17, ISSUE: 3
AUTHORS: Rodrigues, M; Alves, G; Francisco, J; Fortuna, A ; Falcao, A ;
PUBLISHED: 2014, SOURCE: JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, VOLUME: 17, ISSUE: 3
100
TITLE: Third and fourth generation fluoroquinolone antibacterials: A systematic review of safety and toxicity profiles
AUTHORS: Sousa, J; Alves, G; Fortuna, A ; Falcao, A ;
PUBLISHED: 2014, SOURCE: Current Drug Safety, VOLUME: 9, ISSUE: 2
AUTHORS: Sousa, J; Alves, G; Fortuna, A ; Falcao, A ;
PUBLISHED: 2014, SOURCE: Current Drug Safety, VOLUME: 9, ISSUE: 2